263 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
, that the amount of this clause (vi) may exceed the 10% threshold for (I) the commission fee relating to the Employee Retention Credit in an amount … or the extinguishment of any Indebtedness; plus
(iii) any gain realized in connection with the Employee Retention Credit received in the Fiscal Year ending
8-K
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
expected to be paid by the Company in relation to the Employee Retention Credit received in the fiscal year ending on or before December 31, 2024; and (ii … with employee retention credits pursuant to the Coronavirus Aid, Relief, and Economic Security Act. This amount was received in the first quarter of 2024
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
of credit
Repayment of term debt
Proceeds from exercise of employee stock options and purchases
Taxes paid related to net share settlement of equity
8-K
EX-99.1
da77uugc43q
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
aglgdc7qhsap
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
8-K
EX-10.1
s3i radic0e1xi4
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-99.1
j20g5
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
S-8
snk5muz
8 Jun 22
Registration of securities for employees
4:41pm
S-8
up2z03mlu7cgpwi8vla4
8 Jun 22
Registration of securities for employees
4:41pm
S-8
EX-5.1
taqpwo4ej
8 Jun 22
Registration of securities for employees
4:41pm
8-K
wo5nbygh
17 May 22
Departure of Directors or Certain Officers
4:39pm